Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean

BACKGROUND: RotaTeq™ (RV5; Merck & Co. Inc., USA) and Rotarix™ (RV1, GlaxoSmithKline, Belgium) vaccines, developed to prevent rotavirus diarrhea in children under five years old, were both introduced into national immunization programs in 2006. As many countries in Latin America and the Caribbea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pediatr
Main Authors: Velázquez, Raúl F., Linhares, Alexandre C., Muñoz, Sergio, Seron, Pamela, Lorca, Pedro, DeAntonio, Rodrigo, Ortega-Barria, Eduardo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5237165/
https://ncbi.nlm.nih.gov/pubmed/28086819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12887-016-0771-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados